×

Error

There was a problem loading image LEKETlogo11870681_940029516055704_2554505469251269831_n.jpg
×

Message

fsockopen(): unable to connect to ssl://query.yahooapis.com:443 (php_network_getaddresses: getaddrinfo failed: Name or service not known)


March 19, 2012, Netanya Academic College

Netanya Academic College and the S. Daniel Abraham Center for Strategic Dialogue

are honored to invite you to the conference:

Energy as a Platform for Regional Development

Marking the Opening of the Specialization in Management of Natural Resources

and Environmentwithin the Masters in Business Administration

and the opening of the refurbished Tshuva Auditorium

March 19, 2012 at 9:00 a.m., at Tshuva Auditorium

Netanya Academic College1 University St., Netanya Details: 09-8607400

(Please confirm your participation by March 14th, 2012. -

By Email: This email address is being protected from spambots. You need JavaScript enabled to view it. | This email address is being protected from spambots. You need JavaScript enabled to view it.)

Israel and China executed an agreement in a volume of more than NIS 1 billion for the export of Israeli water technologies to China.

On Wednesday, February 29, in Beijing, Minister of Finance Dr. Yuval Steinetz and the Chinese Finance Minister Xie Xuren, signed a financial protocol in a volume of more than NIS 1 billion (US $ 300 million) for the export to China of Israeli water technologies for agricultural use.

The financial protocol is an agreement between the Governments of Israel and of China for setting up a special line of credit for financing trade and Israeli investment in China. The protocol enables the insurance of long-term loans granted to export transactions from Israel on conditions that give the Israeli exporter an edge over his competitors worldwide.

Pursuant to the financial protocol, the Chinese Ministry of Finance will purchase Israeli technologies for the farming communities in the selected provinces. The protocol agreement will enable execution of projects in a volume of more than NIS 1 billion (300 million dollars), in which the Israeli component will constitute at least 50% of the project's value. Integration of the financial protocol into the Chinese five-year plan indicates acknowledgement of Israeli technological capabilities and the importance of the economic and political relations between the countries.

Vaxil's groundbreaking therapeutic vaccine, developed in Israel, could keep about 90 percent of cancers from coming back.
Julian Levy, CEO of Vaxil BioTherapeutics. (MFA)

PM Netanyahu congratulates Technion on New York campus decision.

(Communicated by the Prime Minister's Media Adviser)
Haifa Technion. (businessweek.com)

Israeli computerized model of cancer cell metabolism provides a brand-new platform for finding tailored drug candidates.

(By the MFA)
Researchers from Tel Aviv University believe they are closer to finding a treatment that can kill cancer cells. (MFA)